FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

Whitepapers

The Whitepapers library on FierceBiotech.com contains whitepapers, case studies and research briefs on issues affecting biotechnology, including research and development, marketing and regulation.

If you would like to submit a whitepaper to the library, please visit the following link: Submit a whitepaper



The Definitive IP Address Management (IPAM) Intelligence Whitepaper

Source: 
BlueCat Networks
View this whitepaper to see how IP Address Management (IPAM) is much more than just a marriage between DNS and DHCP. Read more...

ISI White Paper and Recorded Webinar: “Building Blocks, Not Road Blocks to Success”

Source: 
Image Solutions

This white paper and webinar address how emerging life science companies can lay the groundwork for success by synchronizing infrastructure, technology and processes. The goal is to capture data in

Read more...

The Continuing Evolution of the Pharmaceutical Industry: Career Challenges and Opportunities

Source: 
Primary
Author: 
Michael Steiner et al.

A major white paper, “The Continuing Evolution of the Pharmaceutical Industry: Career Challenges and Opportunities,” was published by RegentAtlantic Capital, LLC, a Chatham, New Jersey-based

Read more...

The hottest jobs in science, and how to land them

Source: 
Cold Spring Harbor Laboratory Press

This essential guide provides a comprehensive and systematic overview of careers in the life science industry, with all their ups and downs. The author has conducted interviews with hundreds of key

Read more...

Transforming the Drug Development Process: Finding the critical path to greater efficiency

Source: 
Spotfire

The industry is under pressure to stem drug attrition rates and alter business strategies to account for fewer blockbuster drugs making it to market. But how do you commercialize drugs more quickly

Read more...

10 Tips to Consider when Planning for Accountability, Reconciliation and Destruction of Clinical Trial Material

Source: 
Covance
Author: 
Monica English and Amy Ma, PhD

All experimental compounds tested in humans during clinical development are under stringent control to ensure that these drugs are administered only to eligible patients participating in approved

Read more...

Evolving Roles for Submission Managers

Source: 
Octagon Research Solutions, Inc.
Author: 
Matt Stroschein, Vice President, Regulatory Operations & Data Integration Services

The field of submission or dossier management has changed significantly in recent years. New electronic submission requirements, new technologies and varied agency implementation schedules for eCTD

Read more...

Pharmaceutical Product Commercialization

Source: 
Cutting Edge Information
Increasing R&D costs, generic competition and fragile pipelines make the successful launch of new drugs critically important for pharmaceutical and biotechnology companies. Optimal resource Read more...

The Difference with Biologics: The Scientific, Legal and Regulatory Challenges of Any Follow-On Biologics Scheme

Source: 
BIO
The paper details the legal and regulatory implications of the many important differences between biologics and traditional “small molecule” drugs. Read more...